Related Experiment Video
Updated: Jun 27, 2025
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Emerging biomarkers and molecular targets for precision medicine in cervical cancer
Pankaj Garg1, Madhu Krishna2, Ayalur Raghu Subbalakshmi2
1Department of Chemistry, GLA University, Mathura, Uttar Pradesh 281406, India.
Abstract:
Cervical cancer remains a significant global health burden, necessitating innovative approaches for improved diagnostics and personalized treatment strategies. Precision medicine has emerged as a promising paradigm, leveraging biomarkers and molecular targets to tailor therapy to individual patients. This review explores the landscape of emerging biomarkers and molecular targets in cervical cancer, highlighting their potential implications for precision medicine. By integrating these biomarkers into comprehensive diagnostic algorithms, clinicians can identify high-risk patients at an earlier stage, enabling timely intervention and improved patient outcomes. Furthermore, the identification of specific molecular targets has paved the way for the development of targeted therapies aimed at disrupting key pathways implicated in cervical carcinogenesis. In conclusion, the evolving landscape of biomarkers and molecular targets presents exciting opportunities for advancing precision medicine in cervical cancer. By harnessing these insights, clinicians can optimize treatment selection, enhance patient outcomes, and ultimately transform the management of this devastating disease.
Insights
New biomarkers and molecular targets are revolutionizing cervical cancer care. Precision medicine offers tailored diagnostics and therapies, improving patient outcomes and transforming disease management.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Cervical cancer presents a substantial global health challenge.
- Innovative diagnostic and therapeutic strategies are crucial for improved patient outcomes.
- Precision medicine offers a personalized approach to cancer treatment.
Purpose of the Study:
- To review emerging biomarkers and molecular targets in cervical cancer.
- To highlight their implications for precision medicine.
- To discuss their role in early detection and targeted therapy development.
Main Methods:
- Literature review of recent studies on cervical cancer biomarkers.
- Analysis of molecular targets implicated in cervical carcinogenesis.
- Exploration of diagnostic algorithms integrating novel biomarkers.
Main Results:
- Emerging biomarkers can aid in early identification of high-risk patients.
- Specific molecular targets enable the development of targeted therapies.
- Integration of biomarkers enhances diagnostic accuracy and treatment selection.
Conclusions:
- Biomarkers and molecular targets are key to advancing precision medicine in cervical cancer.
- Personalized treatment strategies can significantly improve patient outcomes.
- These advancements promise to transform the management of cervical cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...